Roger S McIntyre

Roger S McIntyre, MD, FRCPC

Dr. Roger McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and the Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada.

Dr. McIntyre was named by Thomson Reuters in 2014 as one of “The World’s Most Influential Scientific Minds”. This distinction is bestowed upon researchers who publish the most highly cited articles in a variety of scientific fields during the previous decade.

Dr. McIntyre is extensively involved in medical education.  He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto’s Department of Psychiatry and has been selected for the joint Canadian Psychiatric Association (CPA)/Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada.
Dr. McIntyre is the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults with Major Depressive Disorder or Bipolar Disorder and as well a contributor to the CANMAT guidelines for the treatment of Depressive Disorders and Bipolar Disorders. Dr. McIntyre has published hundreds of peer-reviewed articles and has edited and/or co-edited several textbooks on mood disorders.

Dr. McIntyre completed his medical degree at Dalhousie University and completed his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.
Dr. McIntyre is involved in multiple research endeavours which aim to characterize the association between mood disorders, especially cognitive function and medical comorbidity.  Broadly, his work aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.
Eur Neuropsychopharmacol. 2017 Aug 31;:
Mansur RB, Zugman A, Ahmed J, Cha DS, Subramaniapillai M, Lee Y, Lovshin J, Lee JG, Lee JH, Drobinin V, Newport J, Brietzke E, Reininghaus EZ, Sim K, Vinberg M, Rasgon N, Hajek T, McIntyre RS
J Clin Psychiatry. 2017 Jul;78(7):873-881
McIntyre RS, Best MW, Bowie CR, Carmona NE, Cha DS, Lee Y, Subramaniapillai M, Mansur RB, Barry H, Baune BT, Culpepper L, Fossati P, Greer TL, Harmer C, Klag E, Lam RW, Wittchen HU, Harrison J
Eur Child Adolesc Psychiatry. 2017 Aug 30;:
Liao YT, Yang YH, Kuo TY, Liang HY, Huang KY, Wang TN, Lee Y, McIntyre RS, Chen VC
Scand J Pain. 2017 Apr;15:62-67
Cha DS, Carmona NE, Mansur RB, Lee Y, Park HJ, Rodrigues NB, Subramaniapillai M, Rosenblat JD, Pan Z, Lee JH, Lee J, Almatham F, Alageel A, Shekotikhina M, Zhou AJ, Rong C, Harrison J, McIntyre RS
J Clin Psychiatry. 2017 Aug 22;:
Hlis RD, McIntyre RS, Maalouf NM, Van Enkevort E, Brown ES
Neurosci Biobehav Rev. 2017 Aug 19;:
Brietzke E, Cerqueira RO, Mansur RB, McIntyre RS
Rev Bras Psiquiatr. 2017 Jul-Sep;39(3):193-194
Brietzke E, Mansur RB, McIntyre RS
Scientometrics. 2017;112(3):1537-1556
Kudlow P, Cockerill M, Toccalino D, Dziadyk DB, Rutledge A, Shachak A, McIntyre RS, Ravindran A, Eysenbach G
Eur Psychiatry. 2017 Jun 03;45:72-80
Lee JH, Park SK, Ryoo JH, Oh CM, Choi JM, McIntyre RS, Mansur RB, Kim H, Hales S, Jung JY
J Affect Disord. 2017 Jul 11;223:8-9
Scorza FA, Mansur RB, Cerqueira RO, Lafer B, Kapczinski F, McIntyre RS, Brietzke E



Head, Mood Disorders Psychopharmacology Unit, UHN
Professor, Departments of Psychiatry and Pharmacology and Toxicology, University of Toronto